The multidisciplinary team model was determined to be an essential component of providing patient-centered, personalized care for WDTC.
https://bit.ly/4sBEemX
#thyroidCarcinoma
The multidisciplinary team model was determined to be an essential component of providing patient-centered, personalized care for WDTC.
https://bit.ly/4sBEemX
#thyroidCarcinoma
Ensure you are current with the latest best practices in #Oncology nursing. Attend the free live virtual ONA Summit March 20-21 and earn free #CE. Click here to secure your space today!
https://bit.ly/4qjckL5
#ColorectalCancerAwarenessMonth: Nurse-led interventions significantly increase screening adherence (OR=2.51-6.14). Specialized care improves bowel prep and patient quality of life. π©Ί
From @cancercaremascc.bsky.social.
Read the review: https://bit.ly/4aPjoKS
#crcsm #CRCAM
A new web-based ostomy care program tailored for Hispanic patients with #cancer and their caregivers was developed by researchers based on an assessment of patient and caregiver needs. Reported in @jmirpub.bsky.social.
https://bit.ly/4rckEwt
#cancercare
Nurse-led ERAS protocols for LRP significantly improve recovery. Data show reduced incontinence (32.5% vs 56.5%, P<.001) and shorter hospital stays (5.2 vs 6.1 days). π©Ί
From @frontiersin.bsky.social. Read the review: https://bit.ly/4aOgfuR
#MedEd #ProstateCancer #Nursing #pcsm
A new web-based #ostomy care program tailored for Hispanic patients with #cancer and their caregivers was developed by researchers based on an assessment of patient and caregiver needs. Reported in @jmirpub.bsky.social.
https://bit.ly/4rckEwt
#CancerCare
Pain assessment for patients with pulmonary nodules who underwent VATS needs to identify the patientβs pain trajectory category to better address their pain, which can improve their overall #qualityOfLife.
https://bit.ly/4rGnkDx
#LungCancer #LCSM #QoL
β’ Mentorship programs can reduce #nurse turnover by up to 25%.
β’ Effective onboarding improves clinical competency and job satisfaction.
β’ Structured support is vital for retention.
Read more: https://bit.ly/47fA3F0
#NurseRetention #HealthcareLeadership #MedicalEducation
Prehabilitation improves outcomes for non-surgical #cancer patients:
β’ 25% less treatment toxicity β’ Better #HRQoL β’ Enhanced physical function
Read the review: https://bit.ly/4bbN2df
#Oncology #Prehab #CancerCare #Nursing #EvidenceBased
Clinical Snapshot: Mindfulness in #HCC π
β’ Data: IMBI significantly improved resilience & mindfulness (P < .001).
β’ Finding: Reduced anxiety & depression post-intervention.
Read: https://bit.ly/4rycCPn
#Oncology #MentalHealth #HepatocellularCarcinoma
Oncology Nurses in All Roles: Be part of the community that's driving practice change and elevating patient care. Attend 11th Annual ONA Summit on March 20-21 and earn free #CE. Register here: https://bit.ly/4qjckL5
For patients with HER2-positive metastatic #breastcancer, a study suggests that efficacy with the ADC therapy T-DXd is generally consistent across patient subgroups by age, but with some possible variation in certain subgroups.
https://bit.ly/4kRn8Pe
Phase 2: Cooled focal therapy shows 88% success in #prostatecancer at 12 mo. π¬
β’ No urinary incontinence π
β’ 100% potency retention
β’ High QoL profile
Via @bjuijournal.bsky.social @renalurologynews.bsky.social.
Read more: https://bit.ly/4cB2rF9
#GUsm #MedEd #Oncology #pcsm
The 2026 ONA Summit: The #Oncology event your colleagues are talking about. Don't miss your chance to attend this free live virtual event March 20-21 and earn up to 12 CE credits. Register today! https://bit.ly/4qjckL5
Research identifies TB and chronic bronchitis as risk factors for #lungcancer in never-smokers.
β’ TB: 1.51x higher risk π
β’ Chronic bronchitis: 1.25x higher risk
Via @accpchest.bsky.social and @pulmonologyadvisor.bsky.social, read the full review: https://bit.ly/4rjgSlP
#LCSM #MedEd
@fda.gov grants Priority Review to iberdomide for #RRMM.
β’ Target: E3 ligase modulator (CELMoD)
β’ Phase 3 EXCALIBUR results: Improved PFS
β’ Target action date: May 2026
Insights via @medicalprofref.bsky.social.
Read the review: https://bit.ly/3Olgg0s
#mmsm #MultipleMyeloma #FDA
Bilateral mastectomy rates for low-risk HR+ DCIS doubled since 2004, despite no proven survival benefit. π©Ί
β’ 2004: 4.1%
β’ 2022: 8.7%
Insights via @jamanetworkopen.com and @cancertherapyadv.bsky.social.
Read the review: https://bit.ly/3MQNft5
#BCSM #Oncology #MedEd #BreastCancer
Endocrine therapy adherence remains a clinical challenge.
β’ 40% of #breastcancer survivors are non-adherent by year 5.
β’ Side effects and high costs are primary barriers.
β’ Intentional non-adherence is rising.
Read more: https://bit.ly/40gQ4GV
#BCSM #MedEd #Oncology
Register today for the 11th Annual ONA Summit. Free live virtual #CE event March 20-21. Dynamic and interactive presentations led by expert faculty. Designed for #Oncology nurses in all roles. https://bit.ly/4qjckL5
LGB patients face significant #colorectalCancer knowledge gaps and barriers to care. π©Ί
β’ 1 in 6 LGBTQ+ adults avoid care due to discrimination.
β’ Early detection: 91% survival vs. 14% late-stage.
Read the review: https://bit.ly/4aIyZKR
#CRCsm #LGBThealth #Oncology
53.6% of female #cancersurvivors sought nutrition counseling.
Only 57% received professional support.
Primary drivers: weight management and #fertility.
Read more: https://bit.ly/3MA8nna
#Oncology #Nutrition #CancerSurvivorship
Strengthen your #Oncology nursing skills and learn strategies to elevate patient care at the 2026 ONA Summit. Free live virtual #CE event March 20-21 for oncology nurses in all roles. Register now: https://bit.ly/4qjckL5
Skin fluorescent imaging demonstrated high sensitivity and specificity for distinguishing low-risk from high-risk #melanocyticLesions.
https://bit.ly/466Q6oh
#melsm
These findings underscore the need for #caremodels that address #psychosocial disconnection as a core component of #pediatricOncology.
https://bit.ly/4bSe4qW
#PedOnc
Reducing the induction daunorubicin dose among pediatric patients with low-risk B-cell acute #lymphoblasticLeukemia appears to reduce toxicity without compromising efficacy. Published in @ascopost.bsky.social and @hematologyadvisor.bsky.social.
https://bit.ly/4cmwfVQ
#leusm #ALL
The 2026 ONA Summit offers state-of-the-science practice strategies in #Oncology care for oncology nurses in all roles. Secure your space at the March 20-21 free live virtual #CE event here:
Oncology Nurses in All Roles: Empower yourself with the knowledge, tools, and networks needed to stay ahead in #Oncology care. Attend the 2026 ONA Summit March 20-21 and earn free #CE Register here: https://bit.ly/4qjckL5
#ProstateCancer often has a "cold" tumor microenvironment. A novel autovaccine aims to "reawaken" the immune response via patient-specific antigens. π©Ί
Via @renalurologynews.bsky.social: β’ High specificity β’ Low toxicity
Read: https://bit.ly/4rgohC2
#pcsm #oncology #immunotherapy
14% of adults under 35 believe sunscreen is riskier than UV exposure. Clinical intervention is required to counter this trend.
βοΈ SPF 15+ reduces melanoma risk by 50% βοΈ UV is a proven human carcinogen
Read the review: https://bit.ly/46g3OF9
#skcsm #melcsm #nosunscreen
#Prostatecancer metastasis risk is increased for men with vs without cribriform morphology, investigators report. Research from Nikita Sushentsev, MD. Article from @renalurologynews.bsky.social.
https://bit.ly/4t7eEXV
#pcsm